Taking into account the opinions of the Agency, it is appropriate to approve DMPAP as an active substance for use in biocidal products of product-types 2 and 4 subject to compliance with certain conditions.
Recital 8, Regulation (EU) 2023/2089
In forcesince 28 Sep 2023